Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Local Hyperthermia for Warts Treatment04:25

Local Hyperthermia for Warts Treatment

2.3K
Here, we present a protocol for local hyperthermia, a new and effective therapeutic for treating warts. We also showcase its safety and efficacy as an independent...
2.3K
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

7.5K
Transgenic lck:eGFP zebrafish express GFP highly in T lymphocytes, and have been used to study T cell development and acute lymphoblastic leukemia. This line can be used to study B cells, which express lck at lower levels. This protocol describes purification of malignant and non-malignant B cells from lck:eGFP...
7.5K
Enhancing Drug Delivery in Recurrent Glioblastoma with Laser-Induced Hyperthermia01:27

Enhancing Drug Delivery in Recurrent Glioblastoma with Laser-Induced Hyperthermia

133
Begin with an anesthetized human patient diagnosed with recurrent glioblastoma, an invasive tumor characterized by tumor cell infiltration into the surrounding peritumoral region.The peritumoral region retains an intact blood-brain barrier (BBB), where tight junctions between endothelial cells restrict drug penetration.Make an incision in the scalp, create an opening in the skull, and insert a laser probe into the tumor core using MRI guidance.Deliver laser light through the probe.Tissue...
133
In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System06:45

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System

4.7K
This protocol presents techniques and methodology necessary for the accurate delivery of magnetic nanoparticle hyperthermia using a sophisticated delivery and monitoring...
4.7K
Magnetic Hyperthermia-Induced Cell Damage in Murine Microglial Cells01:31

Magnetic Hyperthermia-Induced Cell Damage in Murine Microglial Cells

221
Take adhered murine microglial cells in a multiwell plate.Add polyacrylic acid-coated magnetic nanoparticles (MNPs) to the test well, leaving another well untreated as a control.Incubate the cells to allow MNP uptake via endocytosis, enabling their internalization.Wash with buffer to remove unbound MNPs.Add an enzyme solution to detach the cells.Transfer the detached cells to tubes and centrifuge to pellet them.Discard the supernatant, resuspend the pellet in basal media, and transfer the...
221
A Computational Modeling Approach to Investigate the Influence of Hyperthermia on the Tumor Microenvironment10:23

A Computational Modeling Approach to Investigate the Influence of Hyperthermia on the Tumor Microenvironment

974
The article describes a protocol to simulate the transient temperature profiles and the coupled spatiotemporal variation of the interstitial fluid pressure following the heating delivered by a dipolar radiofrequency hyperthermia system. The protocol can be used to assess the response of biophysical parameters characterizing the tumor microenvironment to interventional hyperthermia techniques.
974

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative Code Status Discussions in Surgical Practice: Results from a National Survey Among Swiss Surgeons.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches·2026
Same author

Reply to: residual risk after familial RYR1 testing: interpreting malignant hyperthermia susceptibility in the context of regional testing strategies.

European journal of human genetics : EJHG·2026
Same author

EMQN Best Practice Guidelines for Genetic Testing and Reporting in RYR1-related disorders.

European journal of human genetics : EJHG·2026
Same author

Labeled surgical caps improve perioperative patient safety and interprofessional communication in the operating room: a scoping review.

Patient safety in surgery·2026
Same author

European Malignant Hyperthermia Group 2025 guidelines for the investigation of malignant hyperthermia susceptibility.

British journal of anaesthesia·2026
Same author

Challenges in perioperative code status management: a national survey among Swiss anaesthetists.

Resuscitation plus·2025

Related Experiment Video

Updated: Jan 19, 2026

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
04:25

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

Published on: November 8, 2024

2.3K

[Malignant Hyperthermia - Diagnosis in Practice].

Thierry Girard, Oliver Bandschapp

    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
    |September 17, 2019
    PubMed
    Summary
    This summary is machine-generated.

    Malignant hyperthermia (MH) susceptibility testing involves genetic screening or in-vitro contracture tests. While genetic tests can confirm MH, only contracture testing can definitively exclude susceptibility.

    More Related Videos

    Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
    08:32

    Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

    Published on: February 22, 2019

    7.5K
    In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
    06:45

    In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System

    Published on: July 2, 2020

    4.7K

    Related Experiment Videos

    Last Updated: Jan 19, 2026

    Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
    04:25

    Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases

    Published on: November 8, 2024

    2.3K
    Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
    08:32

    Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

    Published on: February 22, 2019

    7.5K
    In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
    06:45

    In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System

    Published on: July 2, 2020

    4.7K

    Area of Science:

    • Anesthesiology
    • Medical Genetics
    • Pharmacology

    Background:

    • Malignant hyperthermia (MH) is a severe, unpredictable reaction to certain anesthetic agents.
    • Testing for MH susceptibility is crucial for individuals with a family history or prior suspicious events.

    Purpose of the Study:

    • To outline the diagnostic approaches for malignant hyperthermia susceptibility.
    • To clarify the roles of genetic testing and in-vitro contracture testing in MH diagnosis.

    Main Methods:

    • Review of diagnostic options for MH susceptibility.
    • Discussion of genetic screening and muscle biopsy with in-vitro contracture testing.

    Main Results:

    • Genetic screening can confirm MH susceptibility if a known mutation is present.
    • Absence of identified MH mutations does not rule out susceptibility.
    • In-vitro contracture testing is the definitive method to exclude MH susceptibility.

    Conclusions:

    • Both genetic and contracture testing are valuable for diagnosing MH susceptibility.
    • Contracture testing remains the gold standard for excluding MH susceptibility.